Skip to content

Effect of isopropyl alcohol nasal inhalation and intravenous ondansetron versus placebo on nausea and vomiting in patients with head trauma

Effect of isopropyl alcohol nasal inhalation and intravenous ondansetron versus placebo on nausea and vomiting in patients with head trauma: a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120215009014N271
Enrollment
228
Registered
2019-04-28
Start date
2018-12-25
Completion date
Unknown
Last updated
2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting. Nausea and vomiting

Interventions

Intervention 1: Intervention group 1: Inhalation of saturated pad with 70% isopropyl alcohol for one minute at most 3 times in 2 minutes intervals. Intervention 2: Intervention group 2: Injection of i

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age of 20 to 80 years Mild head trauma (GCS of 14 to 15) Nausea and vomiting

Exclusion criteria

Exclusion criteria: Severe trauma to other parts of the body Hypersensitivity to isopropyl alcohol nasal inhalation and ondansetron Inhalation disorder Mental disorder

Design outcomes

Primary

MeasureTime frame
Assessing the severity of nausea and vomiting. Timepoint: Before the intervention and at 2 and 4 and 6 and 10 minutes after the intervention. Method of measurement: Using visual analog scale (VAS).

Secondary

MeasureTime frame
Assessing the severity of headache. Timepoint: Before the intervention and at 2 and 4 and 6 and 10 minutes after the intervention. Method of measurement: Using visual analog scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohammad Saleh Rasooli

Hamedan University of Medical Sciences

rasoulsl@yahoo.com+98 81 3364 0030

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026